Skip to main content

Table 2 Relationship between circRIP2 level and clinical characteristics in bladder cancer

From: circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway

Total Patients Expression of circRIP2
High Low p
Age (mean) 53.21 51.32 50.27 0.713
Gender
 Male 46 20 26 0.614
 Female 12 5 7  
Tumor stage
 Tis/Ta/T1 33 13 20 0.038
 T2 16 8 8  
 T3/T4 9 4 5  
Grade
 High 34 9 25 0.002
 Low 24 16 8  
Number of tumors
 Solitary 41 22 19 0.584
 Multiple 17 3 14  
Metastasis
 N0 M0 28 17 11 0.012
 N1 M0 18 8 10 0.009
 N1 M1 12 0 12  
Follow-up(month, mean) 33.23 31.83 33.67 0.024a
  1. p < 0.05 represents statistical significance (Chi-square test)
  2. a Results are analyzed by Kaplan-Meier curves and log-rank test